Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration-Reference-Cited by-同舟云学术

Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration

Published:2017-11-13 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Markowitz Joseph,Wang Jiang,Vangundy Zach,You Jia,Yildiz Vedat,Yu Lianbo,Foote Isaac P.,Branson Owen E.,Stiff Andrew R.,Brooks Taylor R.,Biesiadecki Brandon,Olencki Thomas,Tridandapani Susheela,Freitas Michael A.,Papenfuss Tracey,Phelps Mitch A.,Carson William E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14970-0.pdf

Reference55 articles.

1. Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12, 253–268, https://doi.org/10.1038/nri3175 (2012).

2. Gabrilovich, D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4, 941–952, https://doi.org/10.1038/nri1498 (2004).

3. Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. The Journal of experimental medicine 208, 1989–2003, https://doi.org/10.1084/jem.20101158 (2011).

4. Gajewski, T. F., Fuertes, M. B. & Woo, S. R. Innate immune sensing of cancer: clues from an identified role for type I IFNs. Cancer immunology, immunotherapy: CII 61, 1343–1347, https://doi.org/10.1007/s00262-012-1305-6 (2012).

5. Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263–3271 (2002).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

2. Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling;2024-04-01

3. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma;Frontiers in Immunology;2024-02-07

4. Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity;International Journal of Radiation Oncology*Biology*Physics;2024-02

5. Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials;Cancer Research Communications;2024-01-10